Neuronetics, Inc.
NASDAQ:STIMMedical - Diagnostics & Research
+$0.00 today
- Market cap
- $97.16M
- Beta
- 1.04
- P/E (TTM)
- -2.3
- EPS (TTM)
- -$0.53
Volume 2.55M
Average 2.44M
STIM Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Neuronetics, Inc.NASDAQ: STIM
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items growth accelerates
Q1 FY2026 other non-cash items of $2.46M rose 1165.5% year over year, ahead of the -60.8% change in trailing-twelve-month other non-cash items. Sequentially, it rose 186.1% from the prior quarter. Over 3 fiscal years it compounded at +17.9% a year.
Context
- Other non-cash items amounted to 1.3% of revenue in FY2025, down 14.6 pp from a year earlier.
- Other non-cash items increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1165.5% holds above the trailing-twelve-month pace of -60.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 1.87M USD
- Year-over-year change
- -84.2%
- 4-year CAGR
- +19.5%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.87M | -84.2% |
| FY2024 | 2024-12-31 | 11.86M | +305.0% |
| FY2023 | 2023-12-31 | 2.93M | +156.5% |
| FY2022 | 2022-12-31 | 1.14M | +24.4% |
| FY2021 | 2021-12-31 | 918K | — |
Other Non-Cash Items vs competitors
How STIM compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -60.8% is the 9th highest of 10, against a peer median of -2.8%.
- Other non-cash items amounts to 2.9% of revenue for STIM, versus a peer median of 21.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $24.95M USD | -39.4% | -52.6% | 21.9% | |
| LTM Mar 2026 | $15.4M USD | +3205.6% | — | 44.6% | |
| LTM Mar 2026 | $9.73M USD | -57.7% | +151.8% | 1574.8% | |
ATLNAtlantic International Corp. | LTM Dec 2025 | $7M USD | -88.0% | +226.7% | 1.6% |
| LTM Mar 2026 | €6.97M EUR | +470.1% | — | 42.7% | |
| LTM Mar 2026 | $4.93M USD | -58.9% | — | 6.3% | |
| LTM Mar 2026 | $4.59M USD | +5361.5% | — | 24.3% | |
| LTM Mar 2026 | $4.41M USD | -60.8% | +17.9% | 2.9% | |
| LTM Mar 2026 | $2.92M USD | -2.8% | -24.5% | 2.6% | |
| LTM Mar 2026 | $2.65M USD | +166.9% | +95.9% | 9.2% | |
| Peer median (excluding STIM) | — | -2.8% | +95.9% | 21.9% | |
Competitors are the stored peer set for STIM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (31.19M) | (37.16M) | (30.19M) | (43.73M) | (39.14M) |
| Depreciation & Amortization | 1.06M | 1.65M | 2.01M | 2.07M | 3.47M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.87M | 8.75M | 7.32M | 5.6M | 6.85M |
| Change in Working Capital | (6.64M) | (5.12M) | (14.1M) | (6.81M) | 6.58M |
| Accounts Receivables | (3.05M) | (6.66M) | (8.83M) | (3.73M) | 3.54M |
| Inventory | (3.44M) | (2.59M) | (1.1M) | 3.15M | (395K) |
| Accounts Payables | 276K | (1.97M) | 2.03M | (1.99M) | (1.75M) |
| Other Working Capital | (415K) | 6.1M | (6.2M) | (4.25M) | 5.18M |
| Other Non-Cash Items | 918K | 1.14M | 2.93M | 11.86M | 1.87M |
| Operating Cash Flow | (27.98M) | (30.74M) | (32.04M) | (31M) | (20.37M) |
| Capital Expenditures | (2.35M) | (3.27M) | (2.37M) | (1.47M) | (801K) |
| Acquisitions (Net) | 0 | 0 | 0 | (2.55M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 324K | 0 | 0 | 0 | (31K) |
| Other Investing Activities | (7.81M) | 10M | 1.05M | 1.61M | 31K |
| Investing Cash Flow | (9.84M) | 6.73M | (1.32M) | (2.41M) | (801K) |
| Debt Repayment | 0 | 0 | 23.8M | (2.52M) | 9.62M |
| Common Stock Issued | 80.97M | 0 | 0 | 0 | 26.82M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.03M | 207K | (1.1M) | (4.29M) | (594K) |
| Financing Cash Flow | 83.01M | 207K | 22.7M | (6.81M) | 35.85M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 45.18M | (23.8M) | (10.66M) | (40.22M) | 14.68M |
| Free Cash Flow | (30.34M) | (34.01M) | (34.41M) | (32.46M) | (21.18M) |
Neuronetics, Inc.
NASDAQ:STIM
Intrinsic Alpha fair value
Locked
Current Price
$1.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.